Chen Li

Title: Chen Li - Innovator in Pharmaceutical Formulations

Introduction

Chen Li is a notable inventor based in White Plains, NJ (US). He has made significant contributions to the field of pharmaceutical formulations, particularly in the area of reducing subvisible particles in protein compositions. With a total of 2 patents, his work has implications for the stability and efficacy of pharmaceutical products.

Latest Patents

Chen Li's latest patents focus on a process for reducing subvisible particles in a pharmaceutical formulation. The first patent provides a stable protein composition containing a surfactant, which has less than 400 subvisible particles of 10 microns or greater diameter per container, or less than 10,000 subvisible particles of 2 microns or greater per container. The method of manufacturing this stable protein composition includes a unit of operation that removes or decreases esterase activity that degrades the surfactant. This unit of operation may involve techniques such as hydrophobic interaction chromatography or filtration, mixed mode chromatography, or similar methods.

Career Highlights

Chen Li is currently employed at Regeneron Pharmaceuticals, Inc., where he continues to innovate in the pharmaceutical sector. His expertise in protein formulations has positioned him as a valuable asset to his team and the company.

Collaborations

Some of Chen Li's coworkers include Hanne Bak and John Mattila, who contribute to the collaborative environment at Regeneron Pharmaceuticals, Inc. Their combined efforts enhance the research and development of pharmaceutical products.

Conclusion

In summary, Chen Li is a prominent inventor whose work in reducing subvisible particles in pharmaceutical formulations is paving the way for more stable and effective protein compositions. His contributions to Regeneron Pharmaceuticals, Inc. and the field at large are noteworthy and impactful.